Non Hodgkin’s lymphoma —— diffuse,large cell type——– belongs to –
## **Core Concept**
Non-Hodgkin's lymphoma (NHL) is a type of cancer that originates from the lymphatic system, characterized by the abnormal proliferation of lymphocytes. The classification of NHL is based on the cell of origin, morphology, genetic features, and clinical presentation. The diffuse large B-cell lymphoma (DLBCL) is a common subtype of NHL.
## **Why the Correct Answer is Right**
DLBCL is an aggressive type of NHL that accounts for approximately 30% of all NHL cases. It is characterized by the rapid growth of large B cells in the lymph nodes. The **diffuse large B-cell lymphoma** belongs to the category of **B-cell lymphomas**. This subtype is known for its aggressive clinical course but can be potentially cured with chemotherapy and rituximab, a monoclonal antibody targeting the CD20 antigen on B cells.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because DLBCL is specifically known to be of B-cell origin, not T-cell.
- **Option B:** This option might seem plausible but is not the best categorization for DLBCL.
- **Option C:** While there are indolent and aggressive categories within NHL, DLBCL specifically falls under aggressive NHL and is more accurately described by its cell lineage.
- **Option D:** Although Burkitt lymphoma is also a B-cell lymphoma, DLBCL is distinct in its morphology, genetic features, and clinical presentation.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **DLBCL is often treated with R-CHOP** (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), which has significantly improved the prognosis for patients with this disease. Early and accurate diagnosis is crucial for optimal management.
## **Correct Answer:** B.